Marco Marra Selected Research

Marco Marra Research Topics

Disease

18	Neoplasms (Cancer) 10/2020 - 01/2007
3	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2007
2	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2013
2	Carcinogenesis 09/2021 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2014
2	Glioma (Gliomas) 01/2018 - 01/2014
2	Intellectual Disability (Idiocy) 06/2014 - 10/2010
2	Leukemia 03/2013 - 01/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024
1	Uveal melanoma 01/2022
1	Vitiligo 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Desmosterolosis 06/2014
1	Lymphoma (Lymphomas) 12/2013
1	Blast Crisis (Blast Phase) 03/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2013
1	Oligodendroglioma 06/2012
1	Medulloblastoma 04/2012
1	Prostatic Neoplasms (Prostate Cancer) 03/2012
1	Neuroendocrine Carcinoma 03/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2011
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2010
1	ATR-X syndrome 10/2010
1	Thrombocytosis (Thrombocythemia) 01/2010
1	Neutropenia 01/2010
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2007
1	Uterine Cervical Dysplasia 12/2007
1	Iron Overload 08/2002

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 09/2021 - 12/2007
4	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 06/2009
4	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2011
2	Everolimus FDA Link 09/2021 - 12/2019
2	Tyrosine (L-Tyrosine)FDA Link 01/2016 - 12/2013
2	Phosphotransferases (Kinase)IBA 01/2016 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 04/2014 - 10/2010
2	Tyrosine Kinase InhibitorsIBA 12/2013 - 03/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2024
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	IpilimumabIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2021
1	Capecitabine (Xeloda)FDA Link 09/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2021
1	Bevacizumab (Avastin)FDA Link 09/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	TOR Serine-Threonine KinasesIBA 12/2019
1	Proto-Oncogene Proteins c-etsIBA 01/2019
1	veliparibIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Calcibiotic Root Canal SealerIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Histones (Histone)IBA 01/2015
1	CholesterolIBA 06/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 06/2014
1	N,N'-bis(4-azidobenzoyl)cystineIBA 01/2014
1	PhosphotyrosineIBA 12/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2013
1	AcidsIBA 06/2012
1	Formaldehyde (Formol)FDA Link 04/2012
1	ParaffinIBA 04/2012
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 03/2012
1	Capsules (Microcapsules)IBA 03/2012
1	Messenger RNA (mRNA)IBA 03/2012
1	MicroRNAs (MicroRNA)IBA 01/2011
1	GlobinsIBA 10/2010
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2010
1	Contrast MediaIBA 12/2007
1	Gefitinib (Iressa)FDA Link 01/2007
1	ErbB Receptors (EGF Receptor)IBA 01/2007
1	Transferrin Receptors (Transferrin Receptor)IBA 08/2002

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2007
2	Drug Therapy (Chemotherapy) 09/2021 - 11/2017
1	Immunotherapy 01/2022
1	Precision Medicine 10/2020
1	Heterologous Transplantation (Xenotransplantation) 04/2013